Year of Expanding into Circulating Biomarkers
DOI:
https://doi.org/10.33393/jcb.2015.2051Keywords:
Extracellular vesicles, exosomes, microvesicles, circulating tumour cells, cell-free circulating DNA, editorialAbstract
This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Authors contributing to Journal of Circulating Biomarkers agree to publish their articles under the Creative Common Attribution Non Commercial 4.0 (CC-BY-NC 4.0) license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.